Annals of Surgical Oncology Sign the Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Ann Surg Oncol Early Release, published online ahead of print Jan 12 2004
Annals of Surgical Oncology, 10.1245/ASO.2004.03.059
 © 2004 Society of Surgical Oncology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vargas, H. I.
Right arrow Articles by Fenn, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vargas, H. I.
Right arrow Articles by Fenn, A. J.
Related Collections
Right arrow Surgery

Original Articles

Focused Microwave Phased Array Thermotherapy for Ablation of Early-Stage Breast Cancer: Results of Thermal Dose Escalation

Hernan I. Vargas, MD, William C. Dooley, MD, Robert A. Gardner, MD, Katherine D. Gonzalez, RN, Rose Venegas, MD, Sylvia H. Heywang-Kobrunner, MD, Alan J. Fenn, PhD

From Harbor-UCLA Medical Center (HIV, KDG, RV), Torrance, California; The University of Oklahoma (WCD), Health Sciences Center, Oklahoma City, Oklahoma; Columbia Hospital (RAG), West Palm Beach, Florida; Martin-Luther University (SHH-K), Halle, Germany; and Massachusetts Institute of Technology (AJF), Lexington, Massachusetts.

Address correspondence and reprint requests to: Hernan I. Vargas, MD, Division of Surgical Oncology, Harbor-UCLA Medical Center, 1000 W. Carson Street, Torrance, CA 90509; Fax: 310-782-1562.


  Abstract

Background: Tumor ablation as a means of treating breast cancer is being investigated. Microwave energy is promising because it can preferentially heat high-water-content breast carcinomas, compared to adipose and glandular tissues.

Methods: This is a prospective, multicenter, nonrandomized dose-escalation study of microwave treatment. Thermal dose was measured as (1) thermal equivalent minutes (cumulative equivalent minutes; CEM) of treatment relative to a temperature of 43°C and (2) peak tumor temperature. Microwaves were guided by an antenna-temperature sensor placed percutaneously into the tumor. Outcomes measured were pathologic response (tumor necrosis) side effects.

Results: Twenty-five patients (mean age, 57 years) were enrolled. The mean tumor diameter was 1.8 cm. Tumoricidal temperatures (>43°C) were reached in 23 patients (92%). Tumor size was unchanged after thermotherapy (P = not significant). Pathologic necrosis was achieved in 17 (68%) patients. Complete necrosis of the invasive component was achieved in two patients. One hundred forty CEM is predictive of a 50% tumor response, and 210 CEM is predictive of a 100% tumor response (P = .003). Univariate linear regression predicts that peak tumor temperatures of 47.4°C and 49.7°C cause a 50% tumor response and a 100% tumor response, respectively.

Conclusions: Thermotherapy causes tumor necrosis and can be performed safely with minimal morbidity. The degree of tumor necrosis is a function of the thermal dose. Future studies will evaluate the impact of high doses of thermotherapy on margin status and complete tumor ablation.

Key Words: Breast cancer, Ablation, Minimally invasive, Microwave, Cancer treatment.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2004 by the Society of Surgical Oncology.